A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color
Public ClinicalTrials.gov record NCT05372419. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, 24-Week Study to Investigate the Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to determine the safety and efficacy lebrikizumab in adolescent and adult participants with moderate-to-severe atopic dermatitis (AD) and skin of color.
Study identification
- NCT ID
- NCT05372419
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 12, 2023 (Actual)
- Primary completion
- May 3, 2024 (Actual)
- Completion
- Feb 17, 2025 (Actual)
- Last update posted
- Mar 9, 2026
2023 – 2025
United States locations
- U.S. sites
- 36
- U.S. states
- 15
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin and Beauty Dermatology Center, PC | Birmingham | Alabama | 35205 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Center For Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| Axon Clinical Research | Inglewood | California | 90301 | — |
| Avance Clinical Trials Inc | Laguna Niguel | California | 92677 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Wallace Medical Group, Inc. | Los Angeles | California | 90056 | — |
| Cura Clinical Research | Palmdale | California | 93551 | — |
| University of California Davis (UC Davis) Comprehensive Cancer Center | Sacramento | California | 95816 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Cura Clinical Research | Sherman Oaks | California | 91403 | — |
| UConn Health | Farmington | Connecticut | 06030-2840 | — |
| Encore Medical Research of Boynton Beach | Boynton Beach | Florida | 33436 | — |
| Skin Care Research, Inc | Hollywood | Florida | 33021 | — |
| Solutions Through Advanced Research | Jacksonville | Florida | 32256 | — |
| Miami Dermatology and Laser Research | Miami | Florida | 33173 | — |
| Savin Medical Group, LLC | Miami Lakes | Florida | 33014 | — |
| PureSkin Dermatology | Orlando | Florida | 32819 | — |
| Skin Care Physicians of Georgia | Macon | Georgia | 31217 | — |
| Advanced Medical Research | Sandy Springs | Georgia | 30328 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | — |
| Allcutis Research, Inc. | Beverly | Massachusetts | 01915 | — |
| Oakland Hills Dermatology | Auburn Hills | Michigan | 48326 | — |
| Revival Research Institute - Troy | Troy | Michigan | 48084 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Skin Specialists, P.C | Omaha | Nebraska | 68144 | — |
| Sadick Research Group | New York | New York | 10075 | — |
| Wilmington Health Family Medicine | Wilmington | North Carolina | 28411 | — |
| Dermatology & Laser Center of Charleston | Charleston | South Carolina | 29407 | — |
| Arlington Research Center, Inc | Arlington | Texas | 76011 | — |
| Clinical Trial Network | Houston | Texas | 77074 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78218 | — |
| Dermatology Clinical Research Center of San Antonio | San Antonio | Texas | 78229 | — |
| Complete Dermatology | Sugar Land | Texas | 77479 | — |
| Virginia Clinical Research, Inc. | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05372419, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2026 · Synced Nov 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05372419 live on ClinicalTrials.gov.